The Se 3 -I 0.4 treatment induced the most substantial increases, boosting SOD and AP activities by approximately 43% and 40%, respectively, over the control ( P 0.05)
Bariatric surgery itself increases endogenous GLP-1 levels, particularly after RYGB, contributing to improved glycemic control and weight loss
*pun intended
Indeed, riboflavin ameliorates oxidative stress, mitochondrial dysfunction, neuroinflammation, and glutamate excitotoxicity
Reported side effects in humans Clinical experience and user reports suggest that side effects, when they occur, are generally mild
What sets GLP-1s apart from most existing treatments is the possibility that they could work across multiple substance use disorders at the same time, something no approved medication currently does